GlassScriptPhysician profile
John Joesph Tennity
NPI 1194728915
$2,471.66
in general payments reported to CMS, 2019-2025
28 companies · $643 in 2025
The $643 reported for 2025 was more than what a typical Foot & Ankle Surgery provider received nationally (typical 2025 total: $424).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $764 · 2020: $189 · 2021: $112 · 2022: $216 · 2023: $226 · 2024: $322 · 2025: $643.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,190.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,190.01 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $986.04 | 2019-2025 | Variax, Viaflow, Pangea |
| Smith+Nephew, INC. | $237.88 | 2019-2025 | Grafix Pl, Bone Anchors With Arthroscopic Delivery System, Renasys Go V2 Home |
| Depuy Synthes Sales INC. | $237.53 | 2019-2025 | Motoband |
| Treace Medical Concepts, INC. | $158.73 | 2022-2025 | |
| Djo, LLC | $120.99 | 2024-2025 | Cmf |
| Paratek Pharmaceuticals, INC. | $78.11 | 2022-2024 | Nuzyra |
| Heron Therapeutics, INC. | $73.62 | 2021 | |
| Nevro Corp. | $62.74 | 2022 | |
| Polarityte, INC. | $51.53 | 2019 | |
| Vertex Pharmaceuticals Incorporated | $49.12 | 2025 | |
| Conetic Solutions, INC. | $36.02 | 2020 | |
| Linvatec Corporation | $33.34 | 2022 | |
| Integra Lifesciences Corporation | $31.51 | 2019 | |
| Reprise Biomedical, INC. | $30.44 | 2025 | Miro 3d |
| Access Pro Medical, LLC | $29.75 | 2023 | Matriderm |
Show all 28 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Kerecis Limited | $28.24 | 2024-2025 | Kerecis Omega3 Marigen, Kerecis Omega3 Surgiclose, Kerecis Surgiclose |
| Bioventus LLC | $26.28 | 2019 | |
| Arthrosurface Incorporated | $26.10 | 2019 | |
| Pacira Pharmaceuticals Incorporated | $24.95 | 2025 | Exparel |
| Convatec INC. | $21.23 | 2024 | |
| Organogenesis INC. | $20.75 | 2021 | |
| Orthofix Medical, INC. | $19.37 | 2019 | |
| Wright Medical Technology, INC. | $18.23 | 2020 | |
| Janssen Pharmaceuticals, INC | $18.19 | 2019 | |
| Abbott Laboratories | $17.98 | 2021 | |
| Acera Surgical, INC. | $12.86 | 2019 | |
| Zyla Life Sciences, INC. | $11.20 | 2020 | |
| Paragon 28, INC. | $8.93 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John Tennity listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.